| |
Company
Roster
|
|
Total
Insiders : |
41 |
|
|
|
Total
Direct Shares :
|
4,038,919 |
|
|
Total
Indirect Shares :
|
676,555 |
| |
%
Held by Insiders:
|
2.32% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Parshall B Lynne |
Director |
2025-08-06 |
86,344 |
2016-12-15 |
0 |
| Geary Richard S |
EVP, Chief Development Officer |
2025-08-05 |
89,492 |
2009-01-01 |
0 |
| Schneider Eugene |
EVP, Chf Clinical Develop Ofcr |
2025-08-04 |
51,507 |
|
0 |
| Monia Brett P |
Chief Executive Officer, Director |
2025-07-30 |
179,820 |
2012-01-01 |
0 |
| Loscalzo Joseph |
Director |
2025-07-15 |
36,330 |
2015-02-03 |
0 |
| Yang Michael J. |
Director |
2025-07-15 |
6,010 |
2025-01-15 |
0 |
| Diaz Allene M. |
Director |
2025-07-15 |
19,795 |
2022-07-15 |
0 |
| Herman Joan E |
Director |
2025-07-15 |
46,086 |
2020-06-10 |
0 |
| Berthelsen Spencer R |
Director |
2025-07-15 |
156,013 |
2025-07-15 |
70 |
| Hayden Michael R |
Director |
2025-07-15 |
54,298 |
2025-07-15 |
2,000 |
| Baroldi Joseph |
EVP, Chief Business Officer |
2025-04-16 |
31,926 |
2025-04-16 |
3,071 |
| Jenne Kyle |
EVP, Chf GL Pdt Str Ofcr |
2025-04-16 |
11,199 |
|
0 |
| Birchler Brian |
EVP, Corp and Development Ops |
2025-04-16 |
56,660 |
|
0 |
| Oneil Patrick R. |
EVP CLO & General Counsel |
2025-02-28 |
56,799 |
2013-01-01 |
0 |
| Bennett C Frank |
EVP, Chief Scientific Officer |
2025-02-28 |
93,466 |
2003-07-01 |
0 |
| Swayze Eric |
EVP Research |
2025-02-28 |
48,432 |
2025-02-28 |
184 |
| Hougen Elizabeth L |
EVP, Finance & CFO |
2025-01-31 |
110,500 |
2013-01-15 |
0 |
| Devers Shannon L. |
EVP, Chief Human Resources Ofc |
2025-01-16 |
15,937 |
|
0 |
| Klein Joseph III |
Director |
2024-07-16 |
16,346 |
2024-07-16 |
100 |
| Cadoret-Manier Onaiza |
EVP,Chf GL Pdt Str & Oper Ofc |
2024-02-02 |
35,788 |
2021-02-26 |
0 |
| Muto Frederick T |
Director |
2022-07-15 |
59,597 |
2022-07-15 |
1,500 |
| Reikes Peter N |
Director |
2021-10-15 |
14,222 |
|
0 |
| Crooke Stanley T |
Exec Chairman of the Board, Director |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
| Castleman Breaux |
Director |
2020-07-06 |
19,183 |
2014-07-01 |
0 |
| Mcdevitt Damien |
Chief Business Officer |
2019-07-15 |
2,573 |
|
0 |
| Wender Joseph H |
Director |
2018-07-03 |
38,916 |
2025-07-15 |
136,835 |
| Boyce Sarah |
Chief Business Officer |
2018-01-16 |
8,931 |
2016-01-01 |
0 |
| Reed John C |
Director |
2012-09-06 |
0 |
2012-06-22 |
0 |
| Ecker David J |
Vice President |
2008-09-02 |
0 |
2008-09-02 |
28,713 |
| Treble Michael J |
Vice President, Pres of Ibis |
2008-08-11 |
0 |
2007-07-12 |
0 |
| Wedel Mark K |
VP & Chief Medical Officer |
2007-07-06 |
6,603 |
|
0 |
| Levin Arthur A |
Vice President |
2007-04-25 |
1,674 |
2003-07-01 |
0 |
| Brown Richard K |
Vice President |
2006-03-08 |
2,348 |
2006-02-17 |
0 |
| Lilly Eli & Co |
10% Owner |
2005-08-05 |
2,500,000 |
|
0 |
| Lowenstam Patricia |
Vice President |
2004-12-09 |
603 |
2004-12-09 |
247 |
| Stein Aron |
Vice President |
2004-07-01 |
1,536 |
2004-07-01 |
0 |
| Gabrieli Christopher |
Director |
2004-05-14 |
155,431 |
2004-05-14 |
740 |
| De Haan Hans A |
VP, Drug Development |
2004-04-27 |
0 |
|
0 |
| Lundstedt Karen S |
Vice President |
2004-03-10 |
5,407 |
2003-07-01 |
0 |
| Cole Douglas L |
Vice President |
2004-03-09 |
9,616 |
2003-07-01 |
0 |
| Holmlud Jon T |
VP, Development |
2004-01-01 |
7,510 |
2003-07-01 |
5,593 |
|
0.93 (2.17%) 
